GlycoMimetics Inc at Jefferies Healthcare Conference Transcript
Welcome, everyone. And our next presenting company is GlycoMimetics. And I welcome CEO, Harout Semerjian. How are you?
I'm very good. Thank you.
Questions & Answers
Awesome. Yeah. Maybe before we talk about your exciting program and the upcoming catalysts, just for the people who maybe already know GlycoMimetics, but maybe some of them are new to the story, what's your updated elevator pitch for investors?
Thank you, Roger. GlycoMimetics is a clinical-stage company, actually a late-clinical stage company at this point, really focusing on debilitating diseases such as oncology, hematology, inflammatory diseases. We have a proprietary platform dealing with carbohydrates and glycobiology, which we believe is a very exciting area. And now more and more, we're starting to bring some of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |